Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells

Molecular and Cellular Biochemistry

Volumn 359, Issue 1-2, 2012, Pages 431-440

  Kim, Eun Ji ^a   Eom, Soon Ju ^a   Hong, Ji Eun ^a   Lee, Jae Yong ^a   Choi, Myung Sook ^b,c   Park, Jung Han Yoon ^a,b  

^a Hallym University   (South Korea)

^b Kyungpook National University   (South Korea)

^c College of Medicine Hallym University ^*  (South Korea)

Author keywords

Akt; Benzyl isothiocyanate; Breast cancer cells; Hepatocyte growth factor; Migration

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BENZYL ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL; CANCER CELL; CANCER INVASION; CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHORYLATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; ISOTHIOCYANATES; MICE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

MURINAE;

EID: 83555165930     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1039-3     Document Type: Article

References (44)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 277 300 20610543 10.3322/caac.20073
2. AM Gonzalez-Angulo F Morales-Vasquez GN Hortobagyi 2007 Overview of resistance to systemic therapy in patients with breast cancer Adv Exp Med Biol 608 1 22 17993229 10.1007/978-0-387-74039-3-1 1:CAS:528:DC%2BC3cXhtlKgsb7I
3. R Morse J Rodgers M Verrill K Kendell 2003 Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review Eur J Cancer 39 2288 2297 14556919 10.1016/S0959-8049(03)00600-2 1:STN:280: DC%2BD3svnvFSkuw%3D%3D (Pubitemid 37214852)
4. MF Leber T Efferth 2009 Molecular principles of cancer invasion and metastasis (review) Int J Oncol 34 881 895 19287945 1:CAS:528: DC%2BD1MXkt1ejtL4%3D
5. AF Chambers AC Groom IC MacDonald 2002 Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 563 572 12154349 10.1038/nrc865 1:CAS:528:DC%2BD38XlslGqsLw%3D (Pubitemid 37328923)
6. IJ Fidler 2002 The organ microenvironment and cancer metastasis Differentiation 70 498 505 12492492 10.1046/j.1432-0436.2002.700904.x (Pubitemid 36194315)
7. WG Jiang TA Martin C Parr G Davies K Matsumoto T Nakamura 2005 Hepatocyte growth factor, its receptor, and their potential value in cancer therapies Crit Rev Oncol Hematol 53 35 69 15607934 10.1016/j.critrevonc.2004.09.004 (Pubitemid 39656109)
8. TA Martin WG Jiang 2010 Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy Anticancer Agents Med Chem 10 2 6 20015008 1:CAS:528:DC%2BC3cXhsFKksr4%3D
9. MF Di Renzo R Poulsom M Olivero PM Comoglio NR Lemoine 1995 Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer Cancer Res 55 1129 1138 7866999 1:CAS:528:DyaK2MXktVGiurg%3D
10. B Niranjan L Buluwela J Yant N Perusinghe A Atherton D Phippard T Dale B Gusterson T Kamalati 1995 HGF/SF: a potent cytokine for mammary growth, morphogenesis and development Development 121 2897 2908 7555716 1:CAS:528:DyaK2MXotF2mtb4%3D
11. I Tolgay Ocal M Dolled-Filhart TG D'Aquila RL Camp DL Rimm 2003 Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors Cancer 97 1841 1848 12673709 10.1002/cncr.11335 (Pubitemid 36397257)
12. JY Kang M Dolled-Filhart IT Ocal B Singh CY Lin RB Dickson DL Rimm RL Camp 2003 Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer Cancer Res 63 1101 1105 12615728 1:CAS:528:DC%2BD3sXhs1agtLw%3D (Pubitemid 36278444)
13. M Maemura Y Iino T Yokoe J Horiguchi H Takei Y Koibuchi Y Horii I Takeyoshi S Ohwada Y Morishita 1998 Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer Cancer Lett 126 215 220 9585069 10.1016/S0304-3835(98)00014-7 1:CAS:528:DyaK1cXhsFejtro%3D (Pubitemid 28181607)
14. M Toi T Taniguchi T Ueno M Asano N Funata K Sekiguchi H Iwanari T Tominaga 1998 Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer Clin Cancer Res 4 659 664 9533534 1:STN:280:DyaK1c7pt1ajtw%3D%3D (Pubitemid 28193565)
15. JV Higdon B Delage DE Williams RH Dashwood 2007 Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis Pharmacol Res 55 224 236 17317210 10.1016/j.phrs.2007.01.009 1:CAS:528: DC%2BD2sXjvFGnt7c%3D (Pubitemid 46518152)
16. N Miyoshi K Uchida T Osawa Y Nakamura 2004 A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation Cancer Res 64 2134 2142 15026354 10.1158/0008-5472.CAN-03-2296 1:CAS:528:DC%2BD2cXitFCgurg%3D (Pubitemid 38339464)
17. SK Srivastava SV Singh 2004 Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells Carcinogenesis 25 1701 1709 15117814 10.1093/carcin/bgh179 1:CAS:528:DC%2BD2cXntFahsL8%3D (Pubitemid 39214313)
18. D Xiao AA Powolny SV Singh 2008 Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells J Biol Chem 283 30151 30163 18768478 10.1074/jbc.M802529200 1:CAS:528:DC%2BD1cXht1yntL7M
19. R Warin WH Chambers DM Potter SV Singh 2009 Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate Cancer Res 69 9473 9480 19934325 10.1158/0008-5472.CAN-09-2960 1:CAS:528:DC%2BD1MXhsFGrtbbL
20. KC Lai AC Huang SC Hsu CL Kuo JS Yang SH Wu JG Chung 2010 Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway J Agric Food Chem 58 2935 2942 20136087 10.1021/jf9036694 1:CAS:528:DC%2BC3cXhs1ans78%3D
21. X Wu Y Zhu H Yan B Liu Y Li Q Zhou K Xu 2010 Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells BMC Cancer 10 269 20534110 10.1186/1471-2407-10-269
22. Kim EJ, Hong JE, Eom SJ, Lee JY, Park JH (2010) Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat. doi: 10.1007/s10549-010-1299-8
23. T Blick E Widodo H Hugo M Waltham ME Lenburg RM Neve EW Thompson 2008 Epithelial mesenchymal transition traits in human breast cancer cell lines Clin Exp Metastasis 25 629 642 18461285 10.1007/s10585-008-9170-6 1:STN:280:DC%2BD1cvltFelsA%3D%3D
24. EJ Kim PE Holthuizen HS Park YL Ha KC Jung JH Park 2002 Trans-10, cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth Am J Physiol Gastrointest Liver Physiol 283 G357 G367 12121883 1:CAS:528: DC%2BD38XmslSgtrY%3D (Pubitemid 34791302)
25. Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH (2009) Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 20(9):663-676
26. HJ Cho WK Kim EJ Kim KC Jung S Park HS Lee AL Tyner JH Park 2003 Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line Am J Physiol Gastrointest Liver Physiol 284 G996 G1005 12571082 1:CAS:528:DC%2BD3sXltVegtbc%3D (Pubitemid 36597343)
27. EJ Kim IJ Kang HJ Cho WK Kim YL Ha JH Park 2003 Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells J Nutr 133 2675 2681 12888657 1:CAS:528:DC%2BD3sXmt1Sju7Y%3D (Pubitemid 36935990)
28. HJ Cho MR Seon YM Lee J Kim JK Kim SG Kim JH Park 2008 3,3′-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages J Nutr 138 17 23 18156398 1:CAS:528:DC%2BD1cXktVSlug%3D%3D
29. S Fan M Gao Q Meng JJ Laterra MH Symons S Coniglio RG Pestell ID Goldberg EM Rosen 2005 Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection Oncogene 24 1749 1766 15688034 10.1038/sj.onc.1208327 1:CAS:528:DC%2BD2MXhslKms7k%3D (Pubitemid 40461131)
30. WJ Lee WK Chen CJ Wang WL Lin TH Tseng 2008 Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells Toxicol Appl Pharmacol 226 178 191 17961621 10.1016/j.taap.2007.09.013 1:CAS:528: DC%2BD2sXhsVOls7fI (Pubitemid 350297345)
31. FJ Castellino VA Ploplis 2005 Structure and function of the plasminogen/plasmin system Thromb Haemost 93 647 654 15841308 1:CAS:528:DC%2BD2MXjs1ersb0%3D (Pubitemid 40485399)
32. MP Crippa 2007 Urokinase-type plasminogen activator Int J Biochem Cell Biol 39 690 694 17118695 10.1016/j.biocel.2006.10.008 1:CAS:528: DC%2BD2sXivVShsLw%3D (Pubitemid 46366797)
33. ME Meijer-van Gelder MP Look HA Peters M Schmitt N Brunner N Harbeck JG Klijn JA Foekens 2004 Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease Cancer Res 64 4563 4568 15231667 10.1158/0008-5472.CAN-03-3848 1:CAS:528:DC%2BD2cXltlOrsbw%3D (Pubitemid 38856929)
34. MJ Duffy 2002 Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies Clin Chem 48 1194 1197 12142372 1:CAS:528:DC%2BD38XlslKksb8%3D (Pubitemid 34809824)
35. JA Foekens HA Peters MP Look H Portengen M Schmitt MD Kramer N Brunner F Janicke ME Meijer-van Gelder SC Henzen-Logmans WL van Putten JG Klijn 2000 The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients Cancer Res 60 636 643 10676647 1:CAS:528:DC%2BD3cXht1GmtLk%3D (Pubitemid 30094561)
36. K Shirasuna M Saka Y Hayashido H Yoshioka T Sugiura T Matsuya 1993 Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation Cancer Res 53 147 152 8380125 1:CAS:528:DyaK3sXnvVaksQ%3D%3D (Pubitemid 23019390)
37. S Stefansson DA Lawrence 1996 The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin Nature 383 441 443 8837777 10.1038/383441a0 1:CAS:528:DyaK28Xmt1ykur4%3D (Pubitemid 26330833)
38. C Ponzetto A Bardelli Z Zhen F Maina P dalla Zonca S Giordano A Graziani G Panayotou PM Comoglio 1994 A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family Cell 77 261 271 7513258 10.1016/0092-8674(94)90318-2 1:CAS:528: DyaK2cXivFSkur0%3D (Pubitemid 24138623)
39. M Delehedde N Sergeant M Lyon PS Rudland DG Fernig 2001 Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways Eur J Biochem 268 4423 4429 11502202 10.1046/j.1432-1327.2001.02363.x 1:CAS:528:DC%2BD3MXmtlCqu7o%3D (Pubitemid 32862851)
40. S Sipeki E Bander L Buday G Farkas E Bacsy DK Ways A Farago 1999 Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering Cell Signal 11 885 890 10659996 10.1016/S0898-6568(99)00060-1 1:CAS:528:DyaK1MXotVOju7k%3D
41. KL Auer J Contessa S Brenz-Verca L Pirola S Rusconi G Cooper A Abo MP Wymann RJ Davis M Birrer P Dent 1998 The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes Mol Biol Cell 9 561 573 9487126 1:CAS:528:DyaK1cXhs1yktLk%3D (Pubitemid 28125616)
42. P Maroni P Bendinelli E Matteucci MA Desiderio 2007 HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB Carcinogenesis 28 267 279 16840440 10.1093/carcin/bgl129 1:CAS:528:DC%2BD2sXhs1Sku7o%3D (Pubitemid 46321842)
43. D Sliva MT Rizzo D English 2002 Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator J Biol Chem 277 3150 3157 11689575 10.1074/jbc.M109579200 1:CAS:528:DC%2BD38XhtVaks74%3D (Pubitemid 34953176)
44. G Brusewitz BD Cameron LF Chasseaud K Gorler DR Hawkins H Koch WH Mennicke 1977 The metabolism of benzyl isothiocyanate and its cysteine conjugate Biochem J 162 99 107 15557 1:STN:280:DyaE2s7lslWluw%3D%3D (Pubitemid 8017353)